Tag Archives: TXMD

Top Performing Stocks To Own Right Now

The U.K.’s main stock index pulled back Monday, joining in a global selloff that was blamed on worries about Turkey’s precarious financial condition.

Travel-related shares with exposure to Turkey were among the big decliners.

How markets are performing

The FTSE 100
UKX, -0.48%
fell 0.6% to 7,624.33, after tumbling 1% on Friday as concerns over Turkey escalated.

Top Performing Stocks To Own Right Now: TherapeuticsMD, Inc.(TXMD)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on TherapeuticsMD (TXMD)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    TherapeuticsMD Inc (NASDAQ:TXMD) – Investment analysts at Oppenheimer increased their Q3 2018 EPS estimates for shares of TherapeuticsMD in a research report issued to clients and investors on Tuesday, June 5th. Oppenheimer analyst J. Olson now anticipates that the company will post earnings per share of ($0.08) for the quarter, up from their previous estimate of ($0.09). Oppenheimer currently has a “Buy” rating and a $12.00 price target on the stock. Oppenheimer also issued estimates for TherapeuticsMD’s Q4 2018 earnings at ($0.03) EPS, FY2018 earnings at ($0.32) EPS, FY2019 earnings at ($0.10) EPS, FY2020 earnings at $0.22 EPS, FY2021 earnings at $0.44 EPS and FY2022 earnings at $0.70 EPS.

  • [By Joseph Griffin]

    JPMorgan Chase & Co. initiated coverage on shares of TherapeuticsMD (NASDAQ:TXMD) in a report issued on Friday, MarketBeat Ratings reports. The brokerage issued an overweight rating and a $11.00 price target on the stock.

  • [By Motley Fool Transcribing]

    TherapeuticsMD, Inc. (NASDAQ:TXMD) Q4 2018 Earnings Conference CallFeb. 21, 2019 4:30 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

Top Performing Stocks To Own Right Now: ABAXIS Inc.(ABAX)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Abaxis (ABAX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Abaxis (NASDAQ: ABAX) and Image Sensing Systems (NASDAQ:ISNS) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, profitability, institutional ownership, earnings, valuation, risk and analyst recommendations.

  • [By Lisa Levin] Gainers
    Blink Charging Co. (NASDAQ: BLNK) shares jumped 26.5 percent to $6.9042. Blink Charging reported Q1 net income of $2.2 million, versus a year-ago net loss of $3.1 million.
    Eleven Biotherapeutics, Inc. (NASDAQ: EBIO) shares climbed 17.4 percent to $3.11. Eleven Biotherapeutics posted a Q1 loss of $0.11 per share.
    Flanigan's Enterprises, Inc. (NYSE: BDL) shares jumped 17 percent to $27.97 following Q2 results. Flanigan's Enterprises posted Q2 earnings of $0.75 per share on sales of $29.456 million.
    Borqs Technologies, Inc. (NASDAQ: BRQS) rose 15.8 percent to $8.05 after reporting Q1 results.
    Abaxis, Inc. (NASDAQ: ABAX) jumped 15.3 percent to $82.75. Zoetis Inc. (NYSE: ZTS) announced plans to acquire Abaxis for $83 per share in cash.
    21Vianet Group, Inc. (NASDAQ: VNET) gained 15.1 percent to $6.33.
    Gemphire Therapeutics Inc. (NASDAQ: GEMP) rose 13.8 percent to $6.27.
    Enphase Energy, Inc. (NASDAQ: ENPH) gained 12.8 percent to $5.98. H.C. Wainwright initiated coverage on Enphase Energy with a Buy rating.
    PetIQ Inc (NASDAQ: PETQ) shares surged 12.1 percent to $21.68 after reporting a first-quarter sales beat.
    NF Energy Saving Corporation (NASDAQ: NFEC) climbed 11.6 percent to $2.399.
    Allied Healthcare Products, Inc. (NASDAQ: AHPI) surged 11.4 percent to $3.0643.
    Boot Barn Holdings, Inc. (NYSE: BOOT) gained 11.1 percent to $24.40 after the company reported upbeat results for its fourth quarter and issued strong first-quarter earnings guidance.
    Ascena Retail Group, Inc. (NASDAQ: ASNA) rose 10.9 percent to $3.16.
    Sea Limited (NYSE: SE) gained 10.1 percent to $11.71 after reporting Q1 results.
    GEE Group, Inc. (NYSE: JOB) climbed 7.9 percent to $2.61 following Q2 results.
    The ONE Group Hospitality, Inc. (NASDAQ: STKS) gained 7.6 percent to $2.41 after reporting Q1 results.
    Biolinerx Ltd/S ADR (NASDAQ: BLRX) rose 7.3 percent to $0.8798 after the company was granted a patent approval. The clinical-st
  • [By Lisa Levin]

    Abaxis, Inc. (NASDAQ: ABAX) shares were also up, gaining 16 percent to $83.08. Zoetis Inc. (NYSE: ZTS) announced plans to acquire Abaxis for $83 per share in cash.

Top Performing Stocks To Own Right Now: 3M Company(MMM)

Advisors’ Opinion:

  • [By ]

    Cramer was bearish on 3M (MMM) , Fitbit (FIT) and Granite Construction (GVA) .

    Search Jim Cramer’s “Mad Money” trading recommendations using our exclusive “Mad Money” Stock Screener.

  • [By Chris Neiger, Ashraf Eassa, and Reuben Gregg Brewer]

    If you’re in the market for some high-yield stocks that you can hold forever, then you may want to consider Procter & Gamble (NYSE:PG), Broadcom (NASDAQ:AVGO), and 3M (NYSE:MMM).  Read on to find out why three Motley Fool investors view these companies as fantastic dividend stocks to own over the long haul.

  • [By John Rotonti]

    On the other hand, the right investments in R&D efforts to develop new products and services can help companies differentiate themselves from competitors and build sustainable moats. Xylem (NYSE:XYL), a leading pure-play water technology provider, has increased its R&D investments as a percentage of sales to accelerate the pace of innovation across its product portfolio. 3M (NYSE:MMM), with its diversified product portfolio and strong focus on innovation, is another example.

Top Performing Stocks To Own Right Now: PIMCO 25+ Year Zero Coupon US Trs ETF (ZROZ)

Advisors’ Opinion:

  • [By ]

    My preferred fund here is Vanguard Extended Duration Treasury ETF (NYSE: EDV), which owns a basket of long-term, zero-coupon bonds. It’s better-known, larger, and, most important, cheaper than its competitor PIMCO 25+ Year Zero Coupon U.S. Treasury Index Exchange-Traded Fund (NYSE: ZROZ). Both are poised to rally if deflation hits and the stock market falls. But EDV is cheaper, at only 0.07% expense ratio, compared with ZROZ’s 0.15%, and so it’s the one that makes the cut.

Hot Value Stocks To Buy Right Now

Jones Energy Inc (NYSE:JONE) was down 6.8% during trading on Monday . The stock traded as low as $0.46 and last traded at $0.47. Approximately 35,704 shares were traded during mid-day trading, a decline of 97% from the average daily volume of 1,292,978 shares. The stock had previously closed at $0.44.

A number of brokerages recently issued reports on JONE. ValuEngine cut shares of Jones Energy from a “sell” rating to a “strong sell” rating in a research report on Friday, April 27th. Seaport Global Securities reissued a “neutral” rating on shares of Jones Energy in a research report on Wednesday, July 25th. Two equities research analysts have rated the stock with a sell rating and five have given a hold rating to the company’s stock. The company currently has an average rating of “Hold” and a consensus target price of $1.06.

Hot Value Stocks To Buy Right Now: Biglari Holdings Inc.(BH)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Biglari Holdings Inc. (NYSE: BH) were down 17 percent to $352.05. Washington Prime Group Inc. (NYSE: WPG) will replace Biglari Holdings in the S&P SmallCap 600 on Tuesday, May 1.

  • [By Logan Wallace]

    Biglari Holdings (NYSE:BH)’s share price reached a new 52-week high and low during trading on Monday . The company traded as low as $195.09 and last traded at $197.24, with a volume of 16566 shares. The stock had previously closed at $209.09.

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    World Fuel Services Corporation (NYSE: INT) tumbled 18 percent to $22.90 following Q1 results.
    Biglari Holdings Inc. (NYSE: BH) fell 17.4 percent to $349.52. Washington Prime Group will replace Biglari Holdings in the S&P SmallCap 600 on Tuesday, May 1.
    Flex Ltd. (NASDAQ: FLEX) dipped 15.7 percent to $14.03 after a mixed fourth quarter report.
    FormFactor, Inc. (NASDAQ: FORM) fell 15.3 percent to $11.65. FormFactor is expected to release Q1 results on May 2.
    Data I/O Corporation (NASDAQ: DAIO) dropped 14.3 percent to $6.24 following Q1 results.
    National Instruments Corporation (NASDAQ: NATI) fell 14.3 percent to $ 42.34 after reporting Q1 results.
    United States Steel Corporation (NYSE: X) dipped 14.2 percent to $32.37 following Q1 results.
    Civeo Corporation (NYSE: CVEO) dropped 13.5 percent to $3.33. Civeo posted a Q1 loss of $0.42 per share on sales of $101.504 million.
    athenahealth, Inc. (NASDAQ: ATHN) fell 12.4 percent to $125.310 after reporting Q1 results.
    Charter Communications, Inc. (NASDAQ: CHTR) shares tumbled 12.1 percent to $262.06 as the company posted Q1 results.
    Value Line, Inc. (NASDAQ: VALU) fell 11.3 percent to $19.10.
    Federated Investors, Inc. (NYSE: FII) shares dropped 11.2 percent to $27.605 after the company posted downbeat quarterly earnings.
    AV Homes, Inc. (NASDAQ: AVHI) declined 10.7 percent to $17.20 following Q1 results.
    CalAmp Corp. (NASDAQ: CAMP) dropped 9.4 percent to $21.01 after reporting Q4 results.
    Tandem Diabetes Care, Inc. (NASDAQ: TNDM) shares fell 8.9 percent to $7.280 following mixed Q1 results.
    Sony Corporation (NYSE: SNE) shares fell 8.4 percent to $45.97 after reporting Q4 results.
    LogMeIn Inc (NASDAQ: LOGM) fell 8.2 percent to $109.825. LogMeIn reported upbeat earnings for its first quarter, but issued weak second quarter and FY18 earning guidance.
    Eleven Biotherapeutics, Inc. (NASDAQ: EBIO

  • [By Keith Noonan]

    With the year a little more than half over, it’s a good time to take stock of some of the restaurant industry’s biggest underperformers so far. Read on to see why Zoe’s Kitchen (NYSE:ZOES), Arcos Dorados Holdings (NYSE:ARCO), Del Frisco’s Restaurant Group (NASDAQ:DFRG), Biglari Holdings (NYSE:BH), and Yum China Holdings (NYSE:YUMC) have posted big losses in 2018 — and where each stock ranks on the list of the industry’s biggest losers so far.

Hot Value Stocks To Buy Right Now: Bank of Nova Scotia (BNS)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Bank of Nova Scotia (BNS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Bank of Nova Scotia (TSE:BNS) (NYSE:BNS) has been given an average recommendation of “Buy” by the thirteen analysts that are presently covering the stock, Marketbeat Ratings reports. Two research analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average twelve-month price objective among brokers that have updated their coverage on the stock in the last year is C$88.62.

  • [By Lisa Levin] Companies Reporting Before The Bell
    Booz Allen Hamilton Holding Corporation (NYSE: BAH) is estimated to report quarterly earnings at $0.46 per share on revenue of $1.67 billion.
    Momo Inc. (NASDAQ: MOMO) is projected to report quarterly earnings at $0.5 per share on revenue of $396.17 million.
    Multi-Color Corporation (NASDAQ: LABL) is expected to report quarterly earnings at $1.06 per share on revenue of $424.96 million.
    American Woodmark Corporation (NASDAQ: AMWD) is estimated to report quarterly earnings at $1.15 per share on revenue of $382.4 million.
    The Bank of Nova Scotia (NYSE: BNS) is projected to report quarterly earnings at $1.32 per share on revenue of $5.46 billion.
    Jianpu Technology Inc. (NYSE: JT) is expected to report quarterly loss at $0.04 per share on revenue of $47.51 million.
    Trans World Entertainment Corporation (NASDAQ: TWMC) is estimated to report earnings for its first quarter.
    Advanced Drainage Systems, Inc. (NYSE: WMS) is estimated to report quarterly loss at $0.06 per share on revenue of $249.44 million.
    Quotient Limited (NASDAQ: QTNT) is expected to report quarterly loss at $0.48 per share on revenue of $5.73 million.
    Elbit Systems Ltd. (NASDAQ: ESLT) is projected to report earnings for its first quarter.
    Evogene Ltd. (NASDAQ: EVGN) is expected to report earnings for its first quarter.

     

Hot Value Stocks To Buy Right Now: TherapeuticsMD, Inc.(TXMD)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Oppenheimer set a $14.00 target price on TherapeuticsMD (NASDAQ:TXMD) in a research report report published on Wednesday morning. The firm currently has a buy rating on the stock.

  • [By Ethan Ryder]

    Shares of TherapeuticsMD Inc (NASDAQ:TXMD) have been assigned a consensus recommendation of “Buy” from the thirteen brokerages that are presently covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a sell recommendation, three have given a hold recommendation and nine have assigned a buy recommendation to the company. The average 12-month target price among brokers that have covered the stock in the last year is $14.63.

  • [By Max Byerly]

    TherapeuticsMD Inc (NASDAQ:TXMD) saw a significant increase in short interest in the month of August. As of August 31st, there was short interest totalling 61,600,797 shares, an increase of 2.5% from the August 15th total of 60,090,818 shares. Based on an average trading volume of 2,268,705 shares, the days-to-cover ratio is presently 27.2 days. Approximately 35.5% of the company’s stock are sold short.

  • [By Ethan Ryder]

    TherapeuticsMD Inc (NASDAQ:TXMD)’s share price was up 6.4% on Friday . The stock traded as high as $6.07 and last traded at $6.02. Approximately 2,747,655 shares were traded during mid-day trading, an increase of 38% from the average daily volume of 1,984,159 shares. The stock had previously closed at $5.66.

Hot Value Stocks To Buy Right Now: Pinnacle Financial Partners, Inc.(PNFP)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Pinnacle Financial Partners (PNFP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Penn Capital Management Co. Inc. raised its holdings in shares of Pinnacle Financial Partners (NASDAQ:PNFP) by 22.6% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 41,475 shares of the financial services provider’s stock after purchasing an additional 7,651 shares during the quarter. Penn Capital Management Co. Inc. owned 0.05% of Pinnacle Financial Partners worth $2,768,000 at the end of the most recent quarter.

  • [By Max Byerly]

    These are some of the news stories that may have impacted Accern’s scoring:

    Get Pinnacle Financial Partners alerts:

    Equities Analysts Set Expectations for Pinnacle Financial Partners’ Q2 2018 Earnings (PNFP) (americanbankingnews.com) Analysts Expect Pinnacle Financial Partners (PNFP) Will Post Quarterly Sales of $229.21 Million (americanbankingnews.com) Pinnacle Financial Partners’ (PNFP) Outperform Rating Reiterated at Hovde Group (americanbankingnews.com) Pinnacle Financial Partners (PNFP) Receives Average Rating of “Buy” from Brokerages (americanbankingnews.com) Zacks: Analysts Expect Pinnacle Financial Partners (PNFP) to Post $1.15 Earnings Per Share (americanbankingnews.com)

    Several brokerages have recently weighed in on PNFP. Keefe, Bruyette & Woods raised shares of Pinnacle Financial Partners from a “market perform” rating to an “outperform” rating in a report on Friday, February 16th. Zacks Investment Research downgraded shares of Pinnacle Financial Partners from a “buy” rating to a “hold” rating in a report on Thursday, April 5th. Raymond James raised shares of Pinnacle Financial Partners from a “market perform” rating to an “outperform” rating in a report on Tuesday, April 10th. UBS Group raised shares of Pinnacle Financial Partners from a “market perform” rating to an “outperform” rating in a report on Tuesday, April 10th. Finally, Hovde Group reaffirmed an “outperform” rating and issued a $75.00 target price (up previously from $72.00) on shares of Pinnacle Financial Partners in a report on Friday. One analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus price target of $72.56.

  • [By Shane Hupp]

    In related news, Vice Chairman Ronald L. Samuel sold 1,600 shares of the company’s stock in a transaction on Tuesday, November 27th. The stock was sold at an average price of $55.96, for a total transaction of $89,536.00. Following the completion of the sale, the insider now owns 26,375 shares in the company, valued at $1,475,945. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 3.39% of the stock is currently owned by corporate insiders.

    ILLEGAL ACTIVITY WARNING: “Victory Capital Management Inc. Has $70.72 Million Holdings in Pinnacle Financial Partners (PNFP)” was first posted by Ticker Report and is the sole property of of Ticker Report. If you are viewing this piece on another website, it was illegally copied and reposted in violation of US and international copyright & trademark legislation. The correct version of this piece can be accessed at www.tickerreport.com/banking-finance/4151458/victory-capital-management-inc-has-70-72-million-holdings-in-pinnacle-financial-partners-pnfp.html.

    About Pinnacle Financial Partners

  • [By Ethan Ryder]

    Maple Capital Management Inc. boosted its holdings in shares of Pinnacle Financial Partners (NASDAQ:PNFP) by 201.1% during the first quarter, Holdings Channel reports. The fund owned 13,000 shares of the financial services provider’s stock after purchasing an additional 8,683 shares during the quarter. Maple Capital Management Inc.’s holdings in Pinnacle Financial Partners were worth $835,000 at the end of the most recent quarter.

  • [By Logan Wallace]

    Pinnacle Financial Partners (NASDAQ:PNFP) Vice Chairman Ronald L. Samuel sold 1,600 shares of Pinnacle Financial Partners stock in a transaction dated Tuesday, August 28th. The shares were sold at an average price of $64.21, for a total transaction of $102,736.00. Following the completion of the sale, the insider now owns 29,575 shares in the company, valued at $1,899,010.75. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.

Hot Value Stocks To Buy Right Now: Intersil Corporation(ISIL)

Advisors’ Opinion:

  • [By Logan Wallace]

    Media stories about Intersil (NASDAQ:ISIL) have trended somewhat positive this week, Accern reports. The research firm identifies positive and negative press coverage by reviewing more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Intersil earned a media sentiment score of 0.05 on Accern’s scale. Accern also gave headlines about the semiconductor company an impact score of 46.0713234548749 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.

Hot Value Stocks To Buy Right Now: Utah Medical Products, Inc.(UTMD)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Utah Medical Products (NASDAQ:UTMD) was upgraded by investment analysts at BidaskClub from a “buy” rating to a “strong-buy” rating in a research report issued to clients and investors on Monday.

  • [By Max Byerly]

    Utah Medical Products, Inc. (NASDAQ:UTMD) Director Ernst G. Hoyer sold 1,614 shares of the company’s stock in a transaction that occurred on Wednesday, May 9th. The stock was sold at an average price of $104.41, for a total value of $168,517.74. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.

  • [By Max Byerly]

    Utah Medical Products, Inc. (NASDAQ:UTMD) CEO Kevin L. Cornwell sold 8,080 shares of the firm’s stock in a transaction on Friday, June 15th. The stock was sold at an average price of $107.07, for a total value of $865,125.60. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.

Hot Stocks To Invest In 2019

Traders, investors and Star Wars fans alike must be thrilled with Walt Disney Co (DIS, $110.57) these days. As well they should.

In successive days, Disney announced a deal to acquire a large part of 21st Century Fox (FOXA) and debuted the latest installment of the Star Wars saga in a wide release. Whether Star Wars: The Last Jedi can eclipse the $2 billion mark like 2015’s Star Wars: The Force Awakens did (and even beat Episode VII outright) remains to be seen, but its dramatic acquisition of Fox is unquestionably a blockbuster.

Disney stock is trading at a discount to the broader market and sits within reach of its all-time high of $122.08 hit more than two years ago. The blue chip looks like a buy on the heels of this news.

Here’s why.

Disney the Streaming Giant?

Disney is spending $52.4 billion to acquire Fox’s movie and televisions studios, cable and international TV businesses, local sports channels and some other assets.

Hot Stocks To Invest In 2019: Sanofi(SNY)

Advisors’ Opinion:

  • [By Todd Campbell]

    One of these two drugs is Amgen’s (NASDAQ:AMGN) Repatha, and the other is Praluent, which was co-developed by Sanofi SA (NYSE:SNY) and Regeneron Pharmaceuticals (NASDAQ:REGN). Both drugs launched to billion-dollar blockbuster expectations, but because they’re complex biologics that are expensive to make, they cost about $14,000 per year. Their high cost, plus the fact that they’re injected rather than taken orally, may make them best suited for patients with stubbornly high cholesterol who are at the greatest risk of heart disease.

  • [By Todd Campbell]

    Novo Nordisk (NYSE:NVO), Eli Lilly (NYSE:LLY), and Sanofi (NYSE:SNY) are the biggest diabetes drugmakers in the world, and they’re hard at work developing treatments to better control the disease.

  • [By Max Byerly]

    COPYRIGHT VIOLATION NOTICE: “Sanofi (SNY) Stock Rating Reaffirmed by Deutsche Bank” was first posted by Ticker Report and is owned by of Ticker Report. If you are reading this story on another domain, it was illegally stolen and reposted in violation of United States & international copyright & trademark legislation. The original version of this story can be read at www.tickerreport.com/banking-finance/3361890/sanofi-sny-stock-rating-reaffirmed-by-deutsche-bank.html.

  • [By Ethan Ryder]

    Shares of Sanofi (NYSE:SNY) have been given an average recommendation of “Hold” by the sixteen ratings firms that are covering the stock, MarketBeat Ratings reports. Four analysts have rated the stock with a sell recommendation, eight have given a hold recommendation and three have assigned a buy recommendation to the company. The average 12 month price objective among analysts that have updated their coverage on the stock in the last year is $49.33.

  • [By Stephan Byrd]

    Shares of Sanofi SA (NYSE:SNY) have received a consensus recommendation of “Hold” from the sixteen ratings firms that are covering the stock, MarketBeat Ratings reports. Three analysts have rated the stock with a sell rating, nine have assigned a hold rating and three have assigned a buy rating to the company. The average 1-year price objective among brokers that have issued a report on the stock in the last year is $49.33.

Hot Stocks To Invest In 2019: TherapeuticsMD, Inc.(TXMD)

Advisors’ Opinion:

  • [By Stephan Byrd]

    TherapeuticsMD Inc (NASDAQ:TXMD) was down 5% on Tuesday . The company traded as low as $5.80 and last traded at $5.85. Approximately 3,392,267 shares changed hands during trading, an increase of 65% from the average daily volume of 2,057,881 shares. The stock had previously closed at $6.16.

  • [By Stephan Byrd]

    Oppenheimer set a $14.00 target price on TherapeuticsMD (NASDAQ:TXMD) in a research report report published on Wednesday morning. The firm currently has a buy rating on the stock.

  • [By Ethan Ryder]

    TherapeuticsMD Inc (NASDAQ:TXMD)’s share price was up 6.4% on Friday . The stock traded as high as $6.07 and last traded at $6.02. Approximately 2,747,655 shares were traded during mid-day trading, an increase of 38% from the average daily volume of 1,984,159 shares. The stock had previously closed at $5.66.

Hot Stocks To Invest In 2019: CatchMark Timber Trust, Inc.(CTT)

Advisors’ Opinion:

  • [By Max Byerly]

    State Board of Administration of Florida Retirement System acquired a new position in CatchMark Timber Trust (NYSE:CTT) in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 27,894 shares of the financial services provider’s stock, valued at approximately $348,000. State Board of Administration of Florida Retirement System owned 0.06% of CatchMark Timber Trust at the end of the most recent quarter.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Catchmark Timber Trust (CTT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    News stories about Catchmark Timber Trust (NYSE:CTT) have trended positive this week, according to Accern. Accern scores the sentiment of press coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Catchmark Timber Trust earned a media sentiment score of 0.28 on Accern’s scale. Accern also assigned media stories about the financial services provider an impact score of 46.7951009345236 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Catchmark Timber Trust (CTT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Low Price Stocks To Watch For 2019

Dr. Kent Moors

A few years ago, in one of my books (“The Vega Factor”), I coined a phrase to explain the new way in which oil pricing was unfolding, along with the uncertainty resulting from it.

Then, the market was facing rising crude topping $100 a barrel.

Now, the situation finds oil rising into the mid-$60s after a bout of abnormally low prices.

The phenomenon described, however, applies to oil moving in either direction.

I called it “Oil Vega.”

Simply put, it refers to the increasing inability to determine the true value of crude oil based on its market price.

Now, there is a reason why I’m revisiting this phrase now.

You see, I am close to putting the finishing touch on a new investment tool that identifies stocks based on this phenomenon.

And today, I want to give you a sneak peek at one of its main components…

Top 10 Low Price Stocks To Watch For 2019: Plains Group Holdings, L.P.(PAGP)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Plains GP (NYSE:PAGP) was downgraded by equities researchers at Sanford C. Bernstein from an “outperform” rating to a “market perform” rating in a note issued to investors on Monday, The Fly reports.

  • [By Stephan Byrd]

    TheStreet upgraded shares of Plains GP (NYSE:PAGP) from a d+ rating to a c- rating in a research report released on Monday morning.

    Several other analysts have also recently issued reports on the company. Stifel Nicolaus cut Plains GP from a buy rating to a hold rating and set a $24.00 price objective on the stock. in a report on Wednesday. Jefferies Group cut Plains GP from a buy rating to a hold rating in a report on Wednesday, April 25th. Wolfe Research cut Plains GP from a market perform rating to an underperform rating in a report on Tuesday, April 24th. Deutsche Bank began coverage on Plains GP in a report on Thursday, April 19th. They set a buy rating and a $29.00 price objective on the stock. Finally, SunTrust Banks raised Plains GP from a hold rating to a buy rating and set a $27.00 price objective on the stock in a report on Monday, April 9th. Two equities research analysts have rated the stock with a sell rating, eight have given a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the company. The company presently has an average rating of Hold and a consensus price target of $25.65.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Plains GP (PAGP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Here are some of the news articles that may have impacted Accern’s rankings:

    Get Plains GP alerts:

    Plains GP (PAGP) Posts Quarterly Earnings Results, Misses Expectations By $0.08 EPS (americanbankingnews.com) Plains GP (PAGP) Upgraded by TheStreet to C- (americanbankingnews.com) Plains GP (PAGP) Downgraded by Stifel Nicolaus (americanbankingnews.com) Plains GP Holdings (PAGP) Tops Q1 EPS by 5c, Beats on Revenues (streetinsider.com) Plains All American Pipeline, L.P. and Plains GP Holdings Report First-Quarter 2018 Results (finance.yahoo.com)

    Several research firms have commented on PAGP. TheStreet upgraded shares of Plains GP from a “d+” rating to a “c-” rating in a research report on Monday. Stifel Nicolaus cut shares of Plains GP from a “buy” rating to a “hold” rating and set a $24.00 target price for the company. in a research report on Wednesday. Jefferies Group cut shares of Plains GP from a “buy” rating to a “hold” rating in a research report on Wednesday, April 25th. Wolfe Research cut shares of Plains GP from a “market perform” rating to an “underperform” rating in a research report on Tuesday, April 24th. Finally, Deutsche Bank began coverage on shares of Plains GP in a research report on Thursday, April 19th. They issued a “buy” rating and a $29.00 target price for the company. Two research analysts have rated the stock with a sell rating, eight have issued a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the stock. The stock currently has a consensus rating of “Hold” and a consensus target price of $25.65.

  • [By Lisa Levin]

     

    Companies Reporting After The Bell
    Marriott International, Inc. (NASDAQ: MAR) is projected to post quarterly earnings at $1.22 per share on revenue of $5.72 billion.
    Electronic Arts Inc. (NASDAQ: EA) is estimated to post quarterly earnings at $1.04 per share on revenue of $5.68 billion.
    The Walt Disney Company (NYSE: DIS) is projected to post quarterly earnings at $1.68 per share on revenue of $14.05 billion.
    Papa John's International, Inc. (NASDAQ: PZZA) is expected to post quarterly earnings at $0.62 per share on revenue of $441.73 million.
    Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is projected to post quarterly earnings at $2.77 per share on revenue of $434.87 million.
    Sun Life Financial Inc. (NYSE: SLF) is estimated to post quarterly earnings at $0.89 per share on revenue of $6.38 billion.
    LATAM Airlines Group S.A. (NYSE: LTM) is expected to post quarterly earnings at $0.16 per share on revenue of $2.70 billion.
    Liberty Global plc (NASDAQ: LBTYA) is projected to post quarterly earnings at $0.02 per share on revenue of $4.05 billion.
    TripAdvisor, Inc. (NASDAQ: TRIP) is expected to post quarterly earnings at $0.16 per share on revenue of $362.11 million.
    The Wendy's Company (NASDAQ: WEN) is projected to post quarterly earnings at $0.1 per share on revenue of $379.98 million.
    A-Mark Precious Metals, Inc. (NASDAQ: AMRK) is expected to post quarterly earnings at $0.06 per share on revenue of $1.69 billion.
    Monster Beverage Corporation (NASDAQ: MNST) is estimated to post quarterly earnings at $0.4 per share on revenue of $849.38 million.
    Convergys Corporation (NYSE: CVG) is expected to post quarterly earnings at $0.4 per share on revenue of $670.10 million.
    ScanSource, Inc. (NASDAQ: SCSC) is projected to post quarterly earnings at $0.7 per share on revenue of $875.91 million.
    KAR Auction Services, Inc. (NYSE: KAR) is expected to post quarterly earnings at $0.76 per share on revenue of $923.13

Top 10 Low Price Stocks To Watch For 2019: National Steel Corporation(SID)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Companhia Siderurgica Nacional (NYSE:SID)’s share price hit a new 52-week low during trading on Tuesday . The company traded as low as $1.95 and last traded at $1.99, with a volume of 131251 shares. The stock had previously closed at $2.02.

  • [By Rich Smith]

    Confirming that this was not an “oil story” but a “Brazil story,” shares of Brazilian airline Azul SA (NYSE:AZUL) and Brazilian steel company Companhia Siderurgica Nacional (NYSE:SID) likewise declined steeply — closing down 7.2% and 4.8%, respectively. Overall, the Brazilian Ibovespa benchmark stock index closed down 3.7%, after falling as much as 6% in trading earlier in the day.

  • [By Ethan Ryder]

    Daiwa Securities Group Inc. reduced its stake in shares of Companhia Sider煤rgica Nacional (NYSE:SID) by 10.2% during the 1st quarter, Holdings Channel reports. The firm owned 374,200 shares of the basic materials company’s stock after selling 42,600 shares during the quarter. Daiwa Securities Group Inc.’s holdings in Companhia Sider煤rgica Nacional were worth $984,000 at the end of the most recent reporting period.

  • [By Rich Smith]

    Brazilian steelmaker Companhia Siderurgica Nacional (NYSE:SID) stock lost 20% of its value in last month’s sell-off, hurt by a shareholder dispute with management and (probably) continued generally negative sentiment regarding South American stocks. This morning, however, shares of CSN are turning around, and trading up 13% as of 12:30 p.m. EDT.

  • [By Dan Caplinger]

    Monday began the week on a solid note for the stock market, with the Dow Jones Industrial Average posting another triple-digit gain as the Nasdaq Compositeclosed at a record high. Despite ongoing nervousness regarding trade, most investors remain convinced that the strong U.S. economy will be able to lead the way forward, pointing to Friday’s employment report as the latest evidence of sustainable momentum. Good news regarding a host of companies both in the U.S. and abroad also helped buoy the market’s mood. Fossil Group (NASDAQ:FOSL), Companhia Siderurgica Nacional (NYSE:SID), and Immunomedics (NASDAQ:IMMU) were among the best performers on the day. Here’s why they did so well.

Top 10 Low Price Stocks To Watch For 2019: Premier, Inc.(PINC)

Advisors’ Opinion:

  • [By Max Byerly]

    Shares of Premier Inc (NASDAQ:PINC) have earned an average recommendation of “Buy” from the seventeen research firms that are presently covering the company, Marketbeat reports. Seven research analysts have rated the stock with a hold rating and ten have given a buy rating to the company. The average 12-month price objective among brokerages that have issued a report on the stock in the last year is $37.32.

  • [By Shane Hupp]

    Stifel Financial Corp raised its holdings in shares of Premier Inc (NASDAQ:PINC) by 59.2% in the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 12,672 shares of the company’s stock after buying an additional 4,712 shares during the period. Stifel Financial Corp’s holdings in Premier were worth $397,000 as of its most recent SEC filing.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Premier (PINC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Low Price Stocks To Watch For 2019: T2 Biosystems, Inc.(TTOO)

Advisors’ Opinion:

  • [By Max Byerly]

    T2 Biosystems (NASDAQ:TTOO) was upgraded by research analysts at ValuEngine from a “hold” rating to a “buy” rating in a research note issued to investors on Friday.

  • [By Lisa Levin]

    Shares of T2 Biosystems, Inc. (NASDAQ: TTOO) were down 10 percent to $8.00 after the health care company that targets unmet needs received clearance from the FDA. The company said the FDA granted a market clearance for its T2Bacteria Panel for the direct detection of bacterial species in human whole blood specimens from patients with suspected bloodstream infections.

  • [By Ethan Ryder]

    T2 Biosystems Inc (NASDAQ:TTOO) traded up 0.9% during trading on Monday . The stock traded as high as $9.65 and last traded at $9.62. 34,517 shares were traded during mid-day trading, a decline of 97% from the average session volume of 1,220,257 shares. The stock had previously closed at $9.53.

  • [By Shane Hupp]

    T2 Biosystems (NASDAQ:TTOO) hit a new 52-week high and low during trading on Friday . The company traded as low as $7.72 and last traded at $7.38, with a volume of 13220 shares changing hands. The stock had previously closed at $7.22.

  • [By Lisa Levin]

    Shares of T2 Biosystems, Inc. (NASDAQ: TTOO) were down 12 percent to $7.80 after the health care company that targets unmet needs received clearance from the FDA. The company said the FDA granted a market clearance for its T2Bacteria Panel for the direct detection of bacterial species in human whole blood specimens from patients with suspected bloodstream infections.

  • [By Maxx Chatsko]

    Shares of diagnostic test and device developer T2 Biosystems (NASDAQ:TTOO) jumped as much as 16.1% today after a volatile week. The good news is that the company recently announced that the U.S. Food and Drug Administration cleared its T2Bacteria Panel, which is aimed at detecting the presence of sepsis-causing pathogens in blood samples.

Top 10 Low Price Stocks To Watch For 2019: Tahoe Resources, Inc.(TAHO)

Advisors’ Opinion:

  • [By Shane Hupp]

    Tahoe Resources Inc (TSE:THO) (NASDAQ:TAHO) has received a consensus rating of “Hold” from the nine brokerages that are covering the company, Marketbeat.com reports. Four research analysts have rated the stock with a hold recommendation and two have assigned a buy recommendation to the company. The average 1-year price target among analysts that have issued a report on the stock in the last year is C$8.33.

  • [By Shane Hupp]

    TheStreet lowered shares of Tahoe Resources (NYSE:TAHO) (TSE:THO) from a c rating to a d+ rating in a report published on Tuesday.

    A number of other research analysts also recently weighed in on TAHO. Cantor Fitzgerald assumed coverage on Tahoe Resources in a research note on Wednesday, March 28th. They set a buy rating on the stock. Zacks Investment Research downgraded Tahoe Resources from a hold rating to a sell rating in a research note on Thursday, April 26th. ValuEngine downgraded Tahoe Resources from a sell rating to a strong sell rating in a research note on Monday, April 2nd. Finally, Credit Suisse Group downgraded Tahoe Resources from an outperform rating to a neutral rating in a research note on Friday, January 26th. Three investment analysts have rated the stock with a sell rating, five have issued a hold rating and three have assigned a buy rating to the company. Tahoe Resources has an average rating of Hold.

  • [By Logan Wallace]

    Tahoe Resources (TSE:THO) (NASDAQ:TAHO) – Equities research analysts at National Bank Financial reduced their FY2018 earnings estimates for shares of Tahoe Resources in a research report issued on Monday, April 9th. National Bank Financial analyst M. Parkin now forecasts that the company will earn $0.29 per share for the year, down from their prior forecast of $0.35. National Bank Financial currently has a “Sector Perform” rating and a $8.00 price objective on the stock.

  • [By Maxx Chatsko]

    Nonetheless, there are many smaller players with slick investor presentations making promises of big rewards. That could sound intriguing if you’ve caught the gold bug, but it’s important to remember the risks involved when investing in the industry. Luckily, some gold stocks come with big red flags and flashing red lights. Here’s why investors might want to avoid Hecla Mining (NYSE:HL), Tahoe Resources (NYSE:TAHO), and Randgold Resources (NASDAQ:GOLD).

  • [By Shane Hupp]

    Endeavour Silver (NYSE: EXK) and Tahoe Resources (NYSE:TAHO) are both small-cap basic materials companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, dividends, institutional ownership, earnings, valuation, risk and analyst recommendations.

  • [By Joseph Griffin]

    Here are some of the media headlines that may have effected Accern Sentiment Analysis’s analysis:

    Get Tahoe Resources alerts:

    Non-native satin moths impacting aspen foliage in Lake Tahoe (yubanet.com) Tahoe Resources (TAHO) vs. Corvus Gold (CORVF) Financial Survey (americanbankingnews.com) Critical Contrast: Seabridge Gold (SA) and Tahoe Resources (TAHO) (americanbankingnews.com) Analyzing Tahoe Resources (TAHO) and Endeavour Silver (EXK) (americanbankingnews.com) Fourth of July boat inspections at Lake Tahoe (carsonnow.org)

    A number of research firms recently weighed in on TAHO. ValuEngine upgraded Tahoe Resources from a “strong sell” rating to a “sell” rating in a report on Saturday, June 16th. TheStreet downgraded Tahoe Resources from a “c” rating to a “d+” rating in a report on Tuesday, May 22nd. Zacks Investment Research downgraded Tahoe Resources from a “hold” rating to a “strong sell” rating in a report on Wednesday, June 13th. Finally, Cantor Fitzgerald began coverage on Tahoe Resources in a report on Wednesday, March 28th. They issued a “buy” rating for the company. Three equities research analysts have rated the stock with a sell rating, five have given a hold rating and two have assigned a buy rating to the stock. The company has a consensus rating of “Hold”.

Top 10 Low Price Stocks To Watch For 2019: Frontier Communications Corporation(FTR)

Advisors’ Opinion:

  • [By Lisa Levin]

    On Tuesday, the telecommunication services shares climbed 1.33 percent. Meanwhile, top gainers in the sector included Intelsat S.A. (NYSE: I), up 6 percent, and Frontier Communications Corporation (NASDAQ: FTR), up 2 percent.

  • [By Paul Ausick]

    Frontier Communications Corp. (NASDAQ: FTR) traded down about 1.8% Thursday and posted a new 52-week low of $4.90 after closing Tuesday at $4.99. The stock’s 52-week high is $18.21. Volume totaled around 3 million, roughly 25% below the daily average. The company had no specific news and is on track for a gain of 2.5% today.

  • [By Shane Hupp]

    TIM Participacoes (NYSE: TSU) and Frontier Communications (NASDAQ:FTR) are both computer and technology companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, profitability, institutional ownership, dividends, valuation and risk.

Top 10 Low Price Stocks To Watch For 2019: Maiden Hldgs Ltd(MHLD)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Dimensional Fund Advisors LP raised its stake in shares of Maiden Holdings, Ltd. (NASDAQ:MHLD) by 1.9% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 7,015,640 shares of the insurance provider’s stock after purchasing an additional 132,547 shares during the period. Dimensional Fund Advisors LP owned 0.08% of Maiden worth $45,602,000 at the end of the most recent quarter.

  • [By Ethan Ryder]

    Maiden (NASDAQ: MHLD) and Mercury General (NYSE:MCY) are both finance companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, dividends, institutional ownership, analyst recommendations, valuation, earnings and risk.

  • [By Lisa Levin]

     

    Losers
    Netshoes (Cayman) Limited (NASDAQ: NETS) shares dipped 43.73 percent to close at $2.87 on Tuesday as the company posted downbeat Q1 results.
    Cesca Therapeutics Inc. (NASDAQ: KOOL) shares dropped 29.01 percent to close at $0.80 after reporting Q1 results.
    SenesTech, Inc. (NASDAQ: SNES) shares fell 22.2 percent to close at $0.340 after reporting Q1 miss.
    Vipshop Holdings Limited (NYSE: VIPS) fell 19.95 percent to close at $12.08 after the company reported weaker-than-expected earnings for its first quarter on Monday.
    Image Sensing Systems, Inc. (NASDAQ: ISNS) fell 19.68 percent to close at $3.775 after reporting earnings were down year over year. First quarter earnings came in flat, down from 4 cents per share in the same quarter of last year. Sales came in at $3.01 million.
    Boxlight Corporation (NASDAQ: BOXL) dropped 18.47 percent to close at $9.62 on Tuesday after surging 77.44 percent on Monday.
    ENDRA Life Sciences Inc. (NASDAQ: NDRA) declined 16.21 percent to close at $2.43. ENDRA Life Sciences is expected to release quarterly earnings today.
    ALJ Regional Holdings, Inc. (NASDAQ: ALJJ) shares fell 16.13 percent to close at $1.79.
    Switch Inc (NYSE: SWCH) shares dropped 14.93 percent to close at $13.16 following a first-quarter earnings miss.
    Restoration Robotics Inc (NASDAQ: HAIR) fell 14.42 percent to close at $3.68 after reporting a first-quarter earnings miss.
    iCAD, Inc. (NASDAQ: ICAD) declined 13.01 percent to close at $3.41 following Q1 results.
    Intersections Inc. (NASDAQ: INTX) fell 12.44 percent to close at $1.97.
    Histogenics Corporation (NASDAQ: HSGX) declined 12.24 percent to close at $2.15.
    AZZ Inc. (NYSE: AZZ) fell 12.1 percent to close at $39.60 following Q3 earnings.
    Hallador Energy Company (NASDAQ: HNRG) fell 11.1 percent to close at $6.49.
    Integrated Media Technology Limited (NASDAQ: IMTE) dropped 10.66 percent to close at $16.93 on Tuesday.
    Myomo, Inc. (NYSE: MYO) slipp

  • [By Max Byerly]

    Horace Mann Educators (NYSE: HMN) and Maiden (NASDAQ:MHLD) are both small-cap finance companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, risk, dividends, valuation, analyst recommendations, profitability and earnings.

  • [By Lisa Levin]

     

    Companies Reporting After The Bell
    Booking Holdings Inc. (NASDAQ: BKNG) is projected to post quarterly earnings at $10.67 per share on revenue of $2.87 billion.
    CenturyLink, Inc. (NYSE: CTL) is expected to post quarterly earnings at $0.19 per share on revenue of $6.00 billion.
    Albemarle Corporation (NYSE: ALB) is projected to post quarterly earnings at $1.21 per share on revenue of $803.36 million.
    Spectra Energy Partners, LP (NYSE: SEP) is estimated to post quarterly earnings at $0.81 per share on revenue of $751.57 million.
    IAC/InterActiveCorp (NASDAQ: IAC) is expected to post quarterly earnings at $0.8 per share on revenue of $923.80 million.
    Open Text Corporation (NASDAQ: OTEX) is projected to post quarterly earnings at $0.62 per share on revenue of $691.75 million.
    Tutor Perini Corporation (NYSE: TPC) is expected to post quarterly earnings at $0.29 per share on revenue of $1.09 billion.
    Twenty-First Century Fox, Inc. (NASDAQ: FOXA) is projected to post quarterly earnings at $0.54 per share on revenue of $7.41 billion.
    ICU Medical, Inc. (NASDAQ: ICUI) is estimated to post quarterly earnings at $1.84 per share on revenue of $346.28 million.
    TechnipFMC plc (NYSE: FTI) is expected to post quarterly earnings at $0.33 per share on revenue of $3.13 billion.
    Synaptics Incorporated (NASDAQ: SYNA) is projected to post quarterly earnings at $0.91 per share on revenue of $401.76 million.
    The Dun & Bradstreet Corporation (NYSE: DNB) is expected to post quarterly earnings at $1.07 per share on revenue of $386.91 million.
    Matrix Service Company (NASDAQ: MTRX) is estimated to post quarterly earnings at $0.07 per share on revenue of $285.16 million.
    Maiden Holdings, Ltd. (NASDAQ: MHLD) is projected to post quarterly earnings at $0.21 per share on revenue of $739.31 million.
    tronc, Inc. (NASDAQ: TRNC) is expected to post quarterly earnings at $0.65 per share on revenue of $428.25 million.
    Copa Holdings,

Top 10 Low Price Stocks To Watch For 2019: James River Group Holdings, Ltd.(JRVR)

Advisors’ Opinion:

  • [By Max Byerly]

    James River Group (NASDAQ:JRVR) was upgraded by research analysts at BidaskClub from a “hold” rating to a “buy” rating in a note issued to investors on Wednesday.

  • [By Shane Hupp]

    James River Group (NASDAQ: JRVR) and Cincinnati Financial (NASDAQ:CINF) are both finance companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, risk, dividends, analyst recommendations, profitability, earnings and valuation.

Top 10 Low Price Stocks To Watch For 2019: E-House(China)

Advisors’ Opinion:

  • [By ]

    The world’s largest operating utility-scale solar projects are concentrated in China and India, according to IEEFA. Based on company and press reports, as well as its own estimates, those include:

    RankingProject NameSize MWCountryProponent 1Tengger Desert Solar Park1,547ChinaChina National Grid Zhongwei Power Supply Co2Kurnool Ultra Mega Solar Park1,000IndiaAndhra Pradesh Solar Power Corporation Pvt Ltd3Datong Solar Power Top Runner Base1,000ChinaMultiple4Yanchi Ningxia Solar Park1,000ChinaHuawei Technologies Co5Longyangxia Dam Solar Park850ChinaState Power Investment Corporation (China)6Adani Kamuthi Solar Plant648IndiaAdani Green7Solar Star579U.S.BHE Renewables8Topaz Solar Farm550U.S.First Solar9Desert Sunlight Solar Farm550U.S.NextEra Energy, GE Energy Financial & Sumitomo10Nova Olinda Solar Farm292BrazilEnel Green Power

    China added 53 gigawatts of the 98 gigawatts of new solar capacity built last year, a 31 percent increase from the total 2017, IEEFA said, citing Bloomberg New Energy Finance data. Meanwhile, the per unit cost of electricity over the life of a generating asset fell 15 percent year-on-year to $86 a megawatt hour.

Top 10 Low Price Stocks To Watch For 2019: TherapeuticsMD, Inc.(TXMD)

Advisors’ Opinion:

  • [By Brian Feroldi]

    After receiving some analyst love, shares of TherapeuticsMD (NASDAQ:TXMD),a commercial-stage biopharma focused on women’s health, rose 13% as of 3:35 p.m. EDT Tuesday.

  • [By Keith Speights]

    AxovantSciences (NASDAQ:AXON), Deciphera Pharmaceuticals (NASDAQ:DCPH), and TherapeuticsMD (NASDAQ:TXMD) stocks soared by 26% or more this week. What sent these drug stocks into orbit? And are they still buys? Here’s the scoop behind the big gains and what could be next for the companies.

  • [By Lisa Levin]

    Breaking news

    HP Inc (NYSE: HPQ) reported upbeat revenue for its second quarter and raised its profit outlook for the full year. The company named Steve Fieler as its CFO.
    TherapeuticsMD, Inc. (NASDAQ: TXMD) reported the FDA approval of TX-004HR: IMVEXXY (estradiol vaginal inserts) for moderate to severe dyspareunia due to menopause.
    salesforce.com, inc. (NYSE: CRM) reported better-than-expected earnings for its first quarter and raised its forecast for the full year.
    SpartanNash Co (NASDAQ: SPTN) reported upbeat earnings for its first quarter on Tuesday.

  • [By Max Byerly]

    TherapeuticsMD Inc (NASDAQ:TXMD) – Investment analysts at Oppenheimer increased their Q3 2018 EPS estimates for shares of TherapeuticsMD in a research report issued to clients and investors on Tuesday, June 5th. Oppenheimer analyst J. Olson now anticipates that the company will post earnings per share of ($0.08) for the quarter, up from their previous estimate of ($0.09). Oppenheimer currently has a “Buy” rating and a $12.00 price target on the stock. Oppenheimer also issued estimates for TherapeuticsMD’s Q4 2018 earnings at ($0.03) EPS, FY2018 earnings at ($0.32) EPS, FY2019 earnings at ($0.10) EPS, FY2020 earnings at $0.22 EPS, FY2021 earnings at $0.44 EPS and FY2022 earnings at $0.70 EPS.

  • [By Stephan Byrd]

    TherapeuticsMD Inc (NASDAQ:TXMD) was down 5% on Tuesday . The company traded as low as $5.80 and last traded at $5.85. Approximately 3,392,267 shares changed hands during trading, an increase of 65% from the average daily volume of 2,057,881 shares. The stock had previously closed at $6.16.

  • [By Ethan Ryder]

    Shares of TherapeuticsMD Inc (NASDAQ:TXMD) have been assigned a consensus recommendation of “Buy” from the thirteen brokerages that are presently covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a sell recommendation, three have given a hold recommendation and nine have assigned a buy recommendation to the company. The average 12-month target price among brokers that have covered the stock in the last year is $14.63.

Top 10 Performing Stocks To Own Right Now

Top 10 States With Most Millionaires Per Person: 2018

Scottrade Charged Under DOL Fiduciary Rule in Massachusetts

7 Questions About Itemized Deductions Under New Tax Act

Forbes has released its ranking of Best-In-State Wealth Advisors.

This year’s Best-In-State Wealth Advisors list spotlights over 2,000 top-performing advisors across the country who were nominated by their firms — and then researched, interviewed and assigned a ranking within their respective states.

The advisors that are considered have a minimum of seven years of experience.

The ranking, which is developed by SHOOK Research, is based on an algorithm of qualitative criteria and quantitative data. According to Forbes, the algorithm weights factors like revenue trends, assets under management, compliance records, industry experience and those that encompass best practices in their practices and approach to working with clients. 

Here are the No. 1-ranked advisors for each state, according to Forbes’ Best-In-State Wealth Advisors. Check out the full lists for each state at Forbes.

Top 10 Performing Stocks To Own Right Now: Kaman Corporation(KAMN)

Advisors’ Opinion:

  • [By Shane Hupp]

    Kaman Aircraft (NYSE:KAMN) hit a new 52-week high and low on Wednesday . The stock traded as low as $67.95 and last traded at $68.00, with a volume of 2807 shares traded. The stock had previously closed at $67.07.

Top 10 Performing Stocks To Own Right Now: Sunoco LP(SUN)

Advisors’ Opinion:

  • [By ]

    That’s the case for Sunoco (NYSE: SUN). After posting a net loss of $0.09 per share in 2017, the gas station owner is expected to swing to a hefty profit of $2.35 per share in 2018. But of the 14 analysts who follow the company, earnings estimates range as low as $1.22 and as high as $3.35 — so there is a high degree of uncertainty.

  • [By Benzinga News Desk]

    President Donald Trump hinted he may intervene in the Justice Department’s Russia investigation, as a Senate panel advanced a measure to protect Special Counsel Robert Mueller: Link

    ECONOMIC DATA
    USA GDP (QoQ) for Q1 2.30% vs 2.00% Est; Prior 2.90%
    The University of Michigan's consumer confidence index for April is schedule for release at 10:00 a.m. ET.
    The Baker Hughes North American rig count report for the latest week will be released at 1:00 p.m. ET.
    Data on farm prices for the recent week will be released at 3:00 p.m. ET.
    ANALYST RATINGS
    Stifel upgraded Facebook (NASDAQ: FB) from Hold to Buy
    Morgan Stanley upgraded Acacia Communications (NASDAQ: ACIA) from Underweight to Equal-Weight
    Jefferies downgraded Sunoco (NYSE: SUN) from Hold to Underperform
    KBW downgraded Oaktree Capital (NYSE: OAK) from Outperform to Market Perform

    This is a tool used by the Benzinga News Desk each trading day — it's a look at everything happening in the market, in five minutes. To get the full version of this note every morning, click here.

  • [By Matthew DiLallo]

    However, he did rule out the possibility that the company would also roll up its other MLP Sunoco LP (NYSE:SUN). He said that “we’re very pleased with what we’re seeing at SUN as far as the growth that they will be directing that MLP into. And as you know, SUN is younger in the IDR life.” Because of that “for the reasonable future, we don’t see that being rolled up.”

  • [By Matthew DiLallo]

    The only segment where earnings declined was the catch-all one labeled “all other,” which houses different investments such as its stake in Sunoco L.P. (NYSE:SUN) and PES, a refining joint venture. PES has struggled due to higher costs, and recently declared bankruptcy. Meanwhile, Energy Transfer’s earnings from Sunoco L.P. declined because that entity sold the bulk of its retail assets and then used that cash to repurchase a portion of Energy Transfer’s investment.

  • [By Stephan Byrd]

    Sunoco (NYSE: SUN) and Macquarie Infrastructure (NYSE:MIC) are both mid-cap oils/energy companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, profitability, dividends, analyst recommendations, valuation and institutional ownership.

  • [By Joseph Griffin]

    Sunoco (NYSE:SUN) released its quarterly earnings results on Wednesday. The oil and gas company reported ($3.74) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.57 by ($4.31), Briefing.com reports. Sunoco had a return on equity of 17.06% and a net margin of 1.27%. The firm had revenue of $3.75 billion for the quarter, compared to the consensus estimate of $3 billion. During the same quarter in the previous year, the business posted ($0.22) EPS. The firm’s revenue for the quarter was up 33.5% compared to the same quarter last year.

Top 10 Performing Stocks To Own Right Now: Colony Bankcorp Inc.(CBAN)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Media stories about Colony Bankcorp (NASDAQ:CBAN) have trended somewhat positive this week, according to Accern. The research group identifies positive and negative media coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Colony Bankcorp earned a daily sentiment score of 0.02 on Accern’s scale. Accern also gave news stories about the financial services provider an impact score of 48.3992787299045 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the near term.

Top 10 Performing Stocks To Own Right Now: L-3 Communications Holdings, Inc.(LLL)

Advisors’ Opinion:

  • [By Max Byerly]

    Shares of L3 Technologies (NYSE:LLL) have received a consensus recommendation of “Buy” from the fourteen analysts that are presently covering the stock, MarketBeat Ratings reports. Three investment analysts have rated the stock with a hold rating, ten have issued a buy rating and one has issued a strong buy rating on the company. The average 12 month price target among brokerages that have issued a report on the stock in the last year is $223.00.

  • [By Lou Whiteman]

    L-3 Technologies (NYSE:LLL) missed out on much of the rally enjoyed by other defense contractors over the last year. The reason for the lagging performance was because the company was in the middle of a transformation plan aimed at propelling it into the ranks of those larger rivals. Judging by its first-quarter results, the efforts are already beginning to show results.

Top 10 Performing Stocks To Own Right Now: PNM Resources, Inc. (Holding Co.)(PNM)

Advisors’ Opinion:

  • [By Logan Wallace]

    PNM Resources, Inc., through its subsidiaries, engages in the energy and energy-related businesses in the United States. It operates through Public Service Company of New Mexico (PNM) and Texas-New Mexico Power Company (TNMP) segments. The PNM segment is primarily involved in the generation, transmission, and distribution of electricity. It generates electricity using coal, natural gas and oil, nuclear fuel, solar, wind, and geothermal energy sources. As of December 31, 2017, this segment had owned or leased facilities with a total net generation capacity of 2,102 megawatts; and owned 3,200 miles of electric transmission lines, 6,063 miles of distribution overhead lines, 5,828 miles of underground distribution lines, and 254 substations. It also owns and leases office and other equipment, office space, vehicles, and real estate. The TNMP segment provides regulated transmission and distribution services. As of December 31, 2017, this segment owned 978 miles of overhead electric transmission lines, 7,111 miles of overhead distribution lines, 1,241 miles of underground distribution lines, and 116 substations. It also owns and leases vehicles, service facilities, and office locations throughout its service territory. The company serves approximately 773,000 residential, commercial, and industrial customers, as well as end-users of electricity in New Mexico and Texas. PNM Resources, Inc. was founded in 1917 and is headquartered in Albuquerque, New Mexico.

Top 10 Performing Stocks To Own Right Now: Globe Specialty Metals Inc.(GSM)

Advisors’ Opinion:

Top 10 Performing Stocks To Own Right Now: TherapeuticsMD, Inc.(TXMD)

Advisors’ Opinion:

  • [By Ethan Ryder]

    TherapeuticsMD Inc (NASDAQ:TXMD)’s share price was up 6.4% on Friday . The stock traded as high as $6.07 and last traded at $6.02. Approximately 2,747,655 shares were traded during mid-day trading, an increase of 38% from the average daily volume of 1,984,159 shares. The stock had previously closed at $5.66.

  • [By ]

    TherapeuticsMD (Nasdaq: TXMD) is a pharmaceutical company with an exclusive focus on products for women and advanced hormone therapies. Biotech stocks are often a target for short sellers because of the uncertainty around drug development and approvals.

Top 10 Performing Stocks To Own Right Now: TTM Technologies, Inc.(TTMI)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) surged 73.3 percent to $3.90.
    Integrated Media Technology Limited (NASDAQ: IMTE) shares gained 51 percent to $33.1365. The nano-cap low-float stock skyrocketed over 1,300 percent on Wednesday on no company specific news which would support the surge. The move higher is consistent with what was seen in other low-float stocks over the past few months.
    Monaker Group, Inc. (NASDAQ: MKGI) shares jumped 34 percent to $3.00.
    Sharing Economy International Inc. (NASDAQ: SEII) shares rose 28.2 percent to $4.51 after gaining 9.32 percent on Wednesday.
    STAAR Surgical Company (NASDAQ: STAA) shares jumped 27.8 percent to $21.40 after reporting upbeat Q1 results.
    Boxlight Corporation (NASDAQ: BOXL) rose 20.5 percent to $8.920 after climbing 107.87 percent on Wednesday.
    Xspand Products Lab Inc (NASDAQ: XSPL) gained 19.5 percent to $ 5.97. Xspand Products priced its IPO at $5 per share.
    YRC Worldwide Inc. (NASDAQ: YRCW) rose 18.9 percent to $10.035 following upbeat quarterly earnings.
    ENDRA Life Sciences Inc. (NASDAQ: NDRA) gained 18.3 percent to $3.0177. ENDRA Life Sciences is expected to report Q1 results on May 15.
    MYR Group Inc. (NASDAQ: MYRG) rose 18.1 percent to $35.85 after the company posted strong Q1 earnings.
    Rudolph Technologies, Inc. (NASDAQ: RTEC) shares jumped 16 percent to $30.75 following upbeat quarterly earnings.
    TTM Technologies, Inc. (NASDAQ: TTMI) gained 13.7 percent to $16.53 after reporting Q1 results.
    Insight Enterprises, Inc. (NASDAQ: NSIT) shares surged 12 percent to $40.06 following better-than-expected Q1 earnings.
    TreeHouse Foods, Inc. (NYSE: THS) rose 11.8 percent to $40.93 following Q1 results.
    Engility Holdings, Inc. (NYSE: EGL) surged 11.2 percent to $27.36. Engility reported upbeat quarterly earnings.
    Synalloy Corporation (NASDAQ: SYNL) rose 10.7 percent to $19.10 following Q1 results.
    Logitech International S.A. (NASDAQ: LOGI)
  • [By Lisa Levin] Gainers
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares jumped 155.56 percent to close at $5.75 on Thursday.
    Inspire Medical Systems, Inc. (NYSE: INSP) shares gained 56.12 percent to close at $24.98. Inspire Medical went public Thursday on the New York Stock Exchange. The company issued 6.75 million shares priced at $16 each.
    Presbia PLC (NASDAQ: LENS) shares rose 53.02 percent to close at $3.55.
    Integrated Media Technology Limited (NASDAQ: IMTE) shares rose 46.29 percent to close at $32.11. The nano-cap low-float stock skyrocketed over 1,300 percent on Wednesday on no company specific news which would support the surge. The move higher is consistent with what was seen in other low-float stocks over the past few months.
    Technical Communications Corporation (NASDAQ: TCCO) climbed 27.78 percent to close at $5.75.
    STAAR Surgical Company (NASDAQ: STAA) shares gained 26.27 percent to close at $21.15 after reporting upbeat Q1 results.
    Sharing Economy International Inc. (NASDAQ: SEII) shares jumped 22.16 percent to close at $4.30 on Thursday after gaining 9.32 percent on Wednesday.
    China Advanced Construction Materials Group, Inc. (NASDAQ: CADC) rose 20.45 percent to close at $2.65 on Thursday.
    YRC Worldwide Inc. (NASDAQ: YRCW) surged 18.36 percent to close at $9.99 following upbeat quarterly earnings.
    MYR Group Inc. (NASDAQ: MYRG) jumped 17.68 percent to close at $35.74 after the company posted strong Q1 earnings.
    Xspand Products Lab Inc (NASDAQ: XSPL) jumped 17.4 percent to close at $5.87. Xspand Products priced its IPO at $5 per share.
    Coherus BioSciences, Inc. (NASDAQ: CHRS) shares rose 17.32 percent to close at $14.90. Coherus BioSciences reported resubmission of BLA for CHS-1701.
    Rudolph Technologies, Inc. (NASDAQ: RTEC) shares gained 17.17 percent to close at $31.05 following upbeat quarterly earnings.
    The Meet Group, Inc. (NASDAQ: MEET) gained 16.02 percent to close at $2.68 following Q1 earnings.
    Ca

Top 10 Performing Stocks To Own Right Now: Technology Select Sector SPDR ETF (XLK)

Advisors’ Opinion:

  • [By ]

    This movement has done wonders for the technology sector… Consider this: the widely tracked Technology Select Sector ETF (NYSE: XLK) has returned 223% (more than double the S&P 500) since June 29, 2007 — the release date of the first Apple iPhone, which is arguably when smartphones became broadly adopted.

  • [By Jim Crumly]

    Biotech stocks had a big day, with theiShares NASDAQ Biotechnology ETF (NASDAQ:IBB) jumping 2.8%. The broad technology sector slipped, and theTechnology Select Sector SPDR ETF (NYSEMKT:XLK)lost 0.1%.

  • [By Steve Symington]

    Industrials stocks led the way lower today, with the Industrial Select Sector SPDR Fund (NYSEMKT:XLI) falling 1.1%. But tech stocks held up surprisingly well on the heels of yesterday’s losses, with the Technology Select Sector SPDR Fund (NYSEMKT:XLK) wavering between positive and negative territory before closing down just 0.1%.

  • [By Jim Crumly]

    Energy was the strongest sector thanks to a 3.7% rise in crude oil futures; theSPDR S&P Oil & Gas Exploration & Production ETF (NYSEMKT:XOP) jumped 4.2%.Tech stocks also rebounded, with theTechnology Select Sector SPDR ETF (NYSEMKT:XLK) gaining 2.5%.

Top 10 Performing Stocks To Own Right Now: UNIVERSAL INSURANCE HOLDINGS INC(UVE)

Advisors’ Opinion:

  • [By Steve Symington]

    As for individual stocks, GoPro (NASDAQ:GPRO) extended Friday’s gains amid optimism for the action camera and drone specialist’s ongoing turnaround, while shares of Universal Insurance Holdings (NYSE:UVE) rallied on news of the waning storm in Florida.

TherapeuticsMD (TXMD) Trading Up 6.4%

TherapeuticsMD Inc (NASDAQ:TXMD)’s share price was up 6.4% on Friday . The stock traded as high as $6.07 and last traded at $6.02. Approximately 2,747,655 shares were traded during mid-day trading, an increase of 38% from the average daily volume of 1,984,159 shares. The stock had previously closed at $5.66.

Several equities analysts have weighed in on TXMD shares. Cantor Fitzgerald reiterated a “buy” rating and issued a $28.00 target price on shares of TherapeuticsMD in a report on Sunday, January 7th. Zacks Investment Research lowered shares of TherapeuticsMD from a “hold” rating to a “sell” rating in a report on Friday, January 12th. BidaskClub lowered shares of TherapeuticsMD from a “sell” rating to a “strong sell” rating in a report on Wednesday, January 31st. ValuEngine lowered shares of TherapeuticsMD from a “sell” rating to a “strong sell” rating in a report on Friday, March 2nd. Finally, Oppenheimer restated a “buy” rating on shares of TherapeuticsMD in a report on Wednesday, March 21st. Two analysts have rated the stock with a sell rating, two have given a hold rating and eight have assigned a buy rating to the company’s stock. TherapeuticsMD has a consensus rating of “Buy” and a consensus price target of $14.50.

Get TherapeuticsMD alerts:

The firm has a market capitalization of $1,275.68, a P/E ratio of -16.27 and a beta of 1.34.

TherapeuticsMD (NASDAQ:TXMD) last issued its quarterly earnings data on Thursday, May 3rd. The company reported ($0.11) EPS for the quarter, missing the consensus estimate of ($0.10) by ($0.01). TherapeuticsMD had a negative return on equity of 63.67% and a negative net margin of 458.49%. The company had revenue of $3.77 million during the quarter, compared to analyst estimates of $4.18 million. During the same quarter in the prior year, the company posted ($0.11) earnings per share. The business’s revenue was down 5.4% compared to the same quarter last year. sell-side analysts expect that TherapeuticsMD Inc will post -0.39 earnings per share for the current fiscal year.

Several hedge funds have recently modified their holdings of TXMD. Wells Fargo & Company MN increased its stake in TherapeuticsMD by 13.6% during the 3rd quarter. Wells Fargo & Company MN now owns 217,820 shares of the company’s stock worth $1,153,000 after buying an additional 26,007 shares during the period. Schwab Charles Investment Management Inc. increased its stake in TherapeuticsMD by 18.4% during the 4th quarter. Schwab Charles Investment Management Inc. now owns 819,043 shares of the company’s stock worth $4,948,000 after buying an additional 127,410 shares during the period. Edge Wealth Management LLC increased its stake in TherapeuticsMD by 2,500.0% during the 4th quarter. Edge Wealth Management LLC now owns 20,800 shares of the company’s stock worth $125,000 after buying an additional 20,000 shares during the period. Greenwood Capital Associates LLC increased its stake in TherapeuticsMD by 25.9% during the 4th quarter. Greenwood Capital Associates LLC now owns 74,268 shares of the company’s stock worth $449,000 after buying an additional 15,300 shares during the period. Finally, Claraphi Advisory Network LLC purchased a new stake in TherapeuticsMD during the 4th quarter worth approximately $275,000. Hedge funds and other institutional investors own 73.41% of the company’s stock.

About TherapeuticsMD

TherapeuticsMD, Inc is a healthcare company, which focuses on developing and commercializing products for women. Its technology, SYMBODA, develops advanced hormone therapy pharmaceutical products to enable delivery of bio-identical hormones through a variety of dosage forms and administration routes.

Top 10 Warren Buffett Stocks To Invest In 2018

On Feb. 17, 2017, the U.S. total market cap / gross domestic product ratio reached 130%, a critical milestone as valuations remain significantly overvalued. Most of Warren Buffett (Trades, Portfolio)’s portfolio holdings as of Dec. 31, 2016, have price-sales valuations greater than the 80th percentile of the industry. Such companies include The Coca-Cola Co. (NYSE:KO), International Business Machines Corp. (NYSE:IBM), Delta Air Lines Inc. (NYSE:DAL), Apple Inc. (NASDAQ:AAPL) and Southwest Airlines Co. (NYSE:LUV).

Buffett indicator reaches critical milestone

Buffett pointed out that the ratio of the Wilshire 5000 full-cap index over the gross domestic product is “probably the best single measure of where valuations stand at any given moment.” The total market index is currently $24513.4 billion, about 130% of the last reported U.S. GDP. Such market valuations seldom appeared since the dot-com bubble of 2000, when the Buffett indicator reached nearly 150%. Figure 1 shows the historical trendline of the Buffett indicator since 1970.

Top 10 Warren Buffett Stocks To Invest In 2018: Fresh Del Monte Produce, Inc.(FDP)

Advisors’ Opinion:

  • [By Lee Jackson]

    The man at the top of Fresh Del Monte Produce Inc. (NYSE: FDP) wasselling stock last week. Chairman and CEO Mohammad Abu-Ghazaleh shed a block of 50,000 shares at prices that ranged from $57.85 to $58.46 apiece. The total was listed at $2.9 million. The stock ended the weekat $58.31, in a 52-week range of $41.70 to $66.86. The consensus price target is $70.30.

  • [By John Udovich]

    Thanksgiving is almost here and aside from featuring a turkey, most Thanksgiving dinners will include items from a range of consumer stocks including Campbell Soup Company (NYSE: CPB), Kraft Heinz Co (NASDAQ: KHC), Fresh Del Monte Produce Inc (NYSE: FDP) and McCormick & Company (NYSE: MKC) along with aThanksgiving turkey from Hormel Foods Corporation (NYSE: HRL)or Seaboard Corporation (NYSEAMEX: SEB). According tothe American Farm Bureau Federation,a classic Thanksgiving dinner will cost$49.87 for a gathering of 10 orjust under $5 per person down from 2015s all-time high of $50.11.

Top 10 Warren Buffett Stocks To Invest In 2018: Orbital ATK, Inc.(OA)

Advisors’ Opinion:

  • [By Rich Smith]

    While Trump’s nuclear tweet appears to have taken some folks off guard, the fact is that the U.S. has been planning a major upgrade and refurbishmentof its nuclear arsenal for quite some time — since at least the early years of the second Obama administration, in fact. As far back as three years ago, we were writing about a U.S. Air Force effort to begin upgrading the nation’s aging fleet of Minuteman III intercontinental ballistic missiles — a contract that Aerojet Rocketdyne (NYSE:AJRD), among others, is counting on to juice its rocket revenues. Rival rocket scientist Orbital ATK (NYSE:OA) is bidding on the same contract, and whether it’s Aerojet or Orbital that eventually ends up winning this piece of the nuclear rearmament project, there should be money aplenty to go around.

  • [By Rich Smith]

    Orbital ATK (NYSE:OA) occupies a charmed space in the U.S. market for putting satellites in, er, space.

    At one end of the space launch continuum, you have United Launch Alliance, whose Delta IV Heavy launch vehicle, developed by Boeing (NYSE:BA), can put a payload massing in excess of 28 tonsinto orbit in a single launch — at a cost of $350 million.At the other end, new space start-ups like Vector Space are promising to launch a new generation of small satellites into low-earth orbit for prices as little as $2 million a shot. But what about the middle?

  • [By Rich Smith]

    Now consider that as of the last report, Americans owned 265 million guns — but fewer than 1 million silencers. That’s a huge market that American Outdoor Brands and Sturm, Ruger would love to sell into. Easing restrictions on silencer sales could have follow-on effects, too. Granting easier access to suppressors could reduce noise complaints at open-air shooting ranges, making it easier for such businesses to open, which would attract more customers, resulting in more ammunition being used, resulting in more ammunition being sold, resulting in more sales (and profits) for ammo makers such as Olin Corp (NYSE:OLN), Vista Outdoor (NYSE:VSTO), and Orbital ATK (NYSE:OA).

  • [By Lisa Levin]

    Defense giant Northrop Grumman Corporation (NYSE: NOC) confirmed Monday it will buy Orbital ATK Inc (NYSE: OA), the maker of the Pegasus rocket and a vast array of other aerospace and defense systems, in a $9.2 billion deal.

  • [By Jim Robertson]

    Last Monday, U.S. defense contractor Northrop Grumman Corporation (NYSE: NOC) announced it would buy Orbital ATK Inc (NYSE: OA), a direct Aerojet Rocketdyne competitor,for about $7.8 billion (a 22% premium to Orbital’s Friday close) in a deal thatwill give it greater access to lucrative government contracts and expand its arsenal of missile defense systems and space rockets. While Northrop already has a significant presence in payloads, it has not had launcher capability, an area that Orbital brings for both space and missile defense. Orbital also has contracts with NASA and the U.S. Army. The all-cash transaction is the biggest in the defense sector in two years and comes ahead of planned upgrades of U.S. ballistic systems (as the saber rattling by North Korea continues), which are expected to drive demand for missiles.

Top 10 Warren Buffett Stocks To Invest In 2018: Alnylam Pharmaceuticals Inc.(ALNY)

Advisors’ Opinion:

  • [By Brian Orelli]

    Alnylam Pharmaceuticals (NASDAQ:ALNY) jumped as much as 14.5% today after announcing earnings after the bell yesterday. As a development-stage biotech, it wasn’t the revenue or the earnings that caused the spike, but the progression of Allnylam’s pipeline.

  • [By Cory Renauer]

    Treating diseases that have a genetic component by altering the expression of the responsible genes is a promising new field of medicine, but it has been much less straightforward than biopharmaceutical companies had expected. Two contenders in this area, Alnylam Pharmaceuticals (NASDAQ:ALNY) and Ionis Pharmaceuticals (NASDAQ:IONS), saw a mix of setbacks and success in 2016.

  • [By Chris Dier-Scalise]

    On Thursday, the Vetr crowd downgraded Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) from 4.5 stars (Strong Buy), which was issued two days ago, to 3.5 stars (Hold). Crowd sentiment for Alnylam at the time of the downgrade was edging positive, with 66 percent of Vetr user rating bullish.

  • [By Ben Levisohn]

    Yesterday, after markets closed, it was announced that US Federal District Court Judge Sue Robinson ruled to issue a permanent injunction against Praluent, the PCSK9 mAb for hypercholesterolemia from partners Regeneron and Sanofi, due to infringement of patents from Amgen. The court has imposed a 30-day suspension (stay) on the injunction to allow for settlement or appeal of the District Court decision. Sanofi and Regeneron have announced their intent to appeal the ruling to the US Court of Appeals for the Federal Circuit (CAFC). The injunction decision is consistent with our counter-consensus published views communicated on 25 January 2016 (“Downgrade to Sell on evidence of likely infringement of Amgen’s PCSK9 patents”) and subsequently. Based on consultation with expert legal counsel, we now put >75% probability Amgen will prevail on appeal and/or Praluent is ultimately removed from the US market, and/or Amgen achieves a settlement substantially in its favor. We currently model $3.3 bn in non-risk-adjusted 2022E US revenues for Praluent, while consensus models $1.2 bn in 2022E US revenues. We reiterate our view from 25 January 2016 to preferentially own Amgen, The Medicines Company (MDCO) (Buy), and Alnylam (ALNY) (Buy) over Regeneron for exposure to PCSK9 inhibitor market dynamics as outcomes trials approach.

  • [By Lisa Levin]

    Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) shares shot up 53 percent to $114.87 after the company impressed investors with encouraging data from a phase 3 clinical trial. Alnylam, a company dedicated towards treating a wide range of debilitating diseases through ribonucleic acid (RNA) interference (RNAi) therapeutics, said after Tuesday's market close that a phase 3 study called APOLLO met its primary efficacy endpoint and all secondary endpoints.

Top 10 Warren Buffett Stocks To Invest In 2018: Jazz Pharmaceuticals Inc.(JAZZ)

Advisors’ Opinion:

  • [By Jim Robertson]

    The earnings report summarized the following recent milestones:

    The formation of a Scientific Advisory Board (SAB) to provide expert guidance and insight as the Company advances towards product commercialization. in October, Pfenex announced the hiring of Steven Sandoval as Chief Manufacturing Officer.Steven has over 25 years of commercial biopharmaceutical engineering and operations experience, specializing in commercial operations, facility design and licensure of large scale biopharmaceutical commercial manufacturing facilities. Following the announcement in August of the positive Phase 1 trial data for Pfenex’s recombinant anthrax vaccine, discussions with BARDA have been progressing. Pfenex anticipates initiating the PF708 pivotal clinical program by year end. Pfenex entered into a collaboration with Jazz Pharmaceuticals plc (NASDAQ: JAZZ) on multiple hematology/oncology product candidates in July. Regulatory feedback for PF529, Pfenex’s biosimilar candidate to Neulasta (pegfilgrastim), is expected by the end of 2016 and following that feedback, the development path and potential timeline will be outlined.

    Do you like this trading idea and want more trading setups delivered to you every day? Consider investing in a subscription to our SmallCap Network Elite Opportunity (SCN EO) portfolio newsletter or our Under the Radar Movers newsletter where you’ll get more and even better trading setups, investing ideas or tips.

  • [By Keith Speights]

    In December, I included Jazz Pharmaceuticals (NASDAQ:JAZZ) in a list of the three top healthcare stocks investors were overlooking. At that time, I noted that the biotech stock could be a diamond in the rough with its promising pipeline and low valuation.

  • [By Teresa Rivas]

    Jazz Pharmaceuticals (JAZZ) is trading up nearly 9% Thursday, thanks to its settlement with Hikma Pharmaceuticals over the firms patent dispute.

    Pixabay

    As part of the agreement, Hikma will get to sell a generic version of the drug in question, narcolepsy treatment Xyrem, in 2023, for up to five years, while Jazz will get royalties on those sales.

    Janney Montgomery Scotts Ken Trbovich upgraded the shares from Neutral to Buy on the news, and also increased his price target from $138 to $175. From his note:

    While this comes about three years earlier than previous settlements with other generic filers, it eliminates the risk of an earlier launch. Six months thereafter Hikma may launch its own generic and others may potentially be able to launch as well. Importantly, Jazz will receive a meaningful royalty on sales, retain the right to launch its own AG, and can authorize other AGs after the initial 6-month Hikma period.

    Jazz shares are up 8.9% to $153.2o at recent check.

  • [By Lisa Levin] Gainers
    Trevena Inc (NASDAQ: TRVN) rose 10.8 percent to $3.60 in pre-market trading after dropping 4.97 percent on Wednesday.
    Yum China Holdings Inc (NYSE: YUMC) rose 10.2 percent to $31.05 in pre-market trading after the company reported upbeat earnings for its first quarter.
    Seres Therapeutics Inc (NASDAQ: MCRB) rose 9.1 percent to $11.39 in pre-market trading after dropping 5.26 percent on Wednesday.
    Plug Power Inc (NASDAQ: PLUG) rose 8.9 percent to $2.45 in pre-market trading after surging 73.08 percent on Wednesday.
    Coach Inc (NYSE: COH) rose 6.7 percent to $41.98 in pre-market trading. Coach named Ian Bickley as President, Global Business Development and Strategic Alliances.
    Sapiens International Corporation N.V. (NASDAQ: SPNS) shares rose 6.1 percent to $13.91 in pre-market trading after gaining 0.54 percent on Wednesday.
    Jazz Pharmaceuticals plc (NASDAQ: JAZZ) rose 6.1 percent to $149.15 in pre-market trading. Jazz Pharma reached a settlement with Hikma Pharma related to Xyrem patent case. Mizuho downgraded Jazz from Buy to Neutral.
    Interactive Brokers Group, Inc. (NASDAQ: IBKR) shares rose 6 percent to $36.72 in pre-market trading after declining 0.03 percent on Wednesday.
    Rewalk Robotics Ltd (NASDAQ: RWLK) rose 5.3 percent to $2.00 in pre-market trading after the company disclosed that the U.S. Department of Veterans Affairs purchased 28 added Exoskeleton Systems.
    Merrimack Pharmaceuticals Inc (NASDAQ: MACK) rose 5.1 percent to $3.29 in pre-market trading. Merrimack declared a $1.06 special dividend.
    BioTime, Inc. (NYSE: BTX) shares rose 4.8 percent to $3.50 in pre-market trading. BioTime, reported the formation of new subsidiary AgeX Therapeutics, Inc.
    Akari Therapeutics PLC (ADR) (NASDAQ: AKTX) shares rose 4.8 percent to $12.26 in pre-market trading after gaining 0.69 percent on Wednesday.
    Bed Bath & Beyond Inc. (NASDAQ: BBBY) rose 3.6 percent to $39.15 in pre-market trading after the company posted better-than
  • [By Ben Levisohn]

    Jazz Pharmaceuticals (JAZZ) has jumped 6.3% to $149.45 after settling a patent dispute.

    CarMax (KMX) gained 2.4% to $58 after beating earnings and sales forecasts.

Top 10 Warren Buffett Stocks To Invest In 2018: Black Diamond, Inc.(BDE)

Advisors’ Opinion:

  • [By Jim Robertson]

    At the beginning of the week, our Under the Radar Moversnewsletter suggested small cap sporting & outdoor goods stock Black Diamond Inc (NASDAQ: BDE) as a short/bearish trade:

Top 10 Warren Buffett Stocks To Invest In 2018: TherapeuticsMD, Inc.(TXMD)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    On the show’s “Lightning Round” segment, Jim Cramer was bullish on Penn National Gaming (PENN) , KeyCorp (KEY) and TherapeuticsMD (TXMD) .

    Quiet Breakups

  • [By ]

    TherapeuticsMD (Nasdaq: TXMD) is a pharmaceutical company with an exclusive focus on products for women and advanced hormone therapies. Biotech stocks are often a target for short sellers because of the uncertainty around drug development and approvals.

Top 10 Warren Buffett Stocks To Invest In 2018: State Bank Financial Corporation.(STBZ)

Advisors’ Opinion:

  • [By Zacks]

    Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
     
    J P Morgan Chase & Co (NYSE: JPM): Free Stock Analysis Report
     
    Comerica Incorporated (NYSE: CMA): Free Stock Analysis Report
     
    Wells Fargo & Company (NYSE: WFC): Free Stock Analysis Report
     
    Citigroup Inc. (NYSE: C): Free Stock Analysis Report
     
    Wintrust Financial Corporation (NASDAQ: WTFC): Free Stock Analysis Report
     
    Synovus Financial Corp. (NYSE: SNV): Free Stock Analysis Report
     
    State Bank Financial Corporation. (NASDAQ: STBZ): Free Stock Analysis Report
     
    To read this article on Zacks.com click here.
     
    Zacks Investment Research

Top 10 Warren Buffett Stocks To Invest In 2018: Aphria Inc. (APHQF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    When I began writing this, I had a 76% unrealized gain on my position in Aphria Inc (OTCQB:APHQF). It’s crunch time. This is where most sane individuals would be jumping ship and taking earnings. Me? I’m tempted to stay. Aphria has big things happening. The ramifications of the their developing marketplace in Canada are giving Aphria the potential to start reeling in some serious revenues. Furthermore, they have significant holdings in the United States that offer upside if regulatory hurdles don’t get in the way.

  • [By Keith Speights]

    As increasingly more marijuana growers entered the market and more states allowed residents to legally grow marijuana, cannabis prices dropped throughout 2016. Wholesale marijuana prices late in the year were roughly half the levels of 12 months earlier. Will this trend continue — and possibly hurt leading marijuana stocks including Aphria (NASDAQOTH:APHQF),Aurora Cannabis (NASDAQOTH:ACBFF), Medical Marijuana,Inc.(NASDAQOTH:MJNA), and even GW Pharmaceuticals (NASDAQ:GWPH) in the process?

  • [By Sean Williams]

    This rapid growth in legal pot has create quite the demand for marijuana stocks. The seven largest marijuana stocks by market cap have all put on a show over the past couple of years. Here are those seven “green giants” listed with their market caps as of March 17, 2017, along with their trailing one-year total returns.

    GW Pharmaceuticals (NASDAQ:GWPH): $3.0 billion, up 64% Canopy Growth Corp. (NASDAQOTH:TWMJF): $904 million, up 259% Aphria (NASDAQOTH:APHQF) $440 million, up 381% Aurora Cannabis (NASDAQOTH:ACBFF): $482 million, up 299% AXIM Biotechnologies (NASDAQOTH:AXIM): $562 million, up 1,720% Corbus Pharmaceuticals (NASDAQ:CRBP): $450 million, up 431% Medical Marijuana (NASDAQOTH:MJNA): $221 million, up 254%

    As you can see, these are some hefty valuations — and some exceptionally strong moves higher on the heels of marijuana’s expansion. With the exception of GW Pharmaceuticals, every one of the largest marijuana stocks has at least tripled in value over the trailing 12 months, with cannabinoid-based drug developer AXIM Biotechnologies skyrocketing more than 1,700%!

  • [By SEEKINGALPHA.COM]

    Aphria (OTCQB:APHQF) just did something very unusual and frankly caught us by surprise. The company announced that it is amending its previously announced transaction with Nuuvera (OTC:NUUVF) by which the cash portion of the consideration will be lowered from $1.00 to $0.60. The announcement surprised us as our past experience suggested that lowering purchase price post-deal announcement is extremely uncommon, especially in the absence of major negative developments at the target. Simultaneously, Nuuvera announced that it is acquiring the remaining 49% minority interest in Avanti Rx Analytics from a minority shareholder for $43 million. Avanti is a subsidiary of Nuuvera that provides research and testing services for cannabis companies. Nuuvera claimed that the reduced cash offer helps fund its acquisition, which makes no sense for us.

  • [By Javier Hasse]

    Also quite recently, Benzinga asked Alan Brochstein, founding partner at New Cannabis Ventures and founder at 420 Investor, about plays in the marijuana industry against such an uncertain backdrop. The expert mentioned a few Canadian Licensed Producers, including AURORA CANNABIS IN COM NPV (OTC: ACBFF), APHRIA INC NPV (OTC: APHQF), METTRUM HEALTH COR COM NPV (OTC: MQTRF), ORGANIGRAM HLDGS I COM NPV (OTC: OGRMF), SUPREME PHARMACEUT COM NPV (OTC: SPRWF) and CANOPY GROWTH CORP COM NPV (OTC: TWMJF), as well as “the only” biotech stock in the space, GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH).

Top 10 Warren Buffett Stocks To Invest In 2018: Mitel Networks Corporation(MITL)

Advisors’ Opinion:

  • [By Lisa Levin]

    ShoreTel Inc (NASDAQ: SHOR) shares shot up 28 percent to $7.47. Mitel Networks Corp (NASDAQ: MITL) announced plans to acquire Shortel for $7.50 per share in cash.

Top 10 Warren Buffett Stocks To Invest In 2018: PetroChina Company Limited(PTR)

Advisors’ Opinion:

  • [By Money Morning News Team]

    PetroChina Co. Ltd. (NYSE ADR: PTR) is China’s largest oil company with a market cap of $216.52 billion. PTR is partially owned by the Chinese government.